As for the CEO's puzzlement of stock price that's easy. It trades on the OTC. if they want a more reflective stock price they will need to reverse stock split and list on the NASDAQ. Anything short of that and the stock price won't move much In my opinion. What's your guys'take on that?
This is by far the most important detail from the cc in my mind. If they can show that the ccr5 cell is the gateway for many cancers, then we have a very valuable patent. Getting this phase 2 trial enrolled and some preliminary data is so important.
The more we look at this future, the more nader’s frustration about the sp looks stupid. He needs to start owning the sp situation and providing solutions, not commiserate.
News 
Market Data 
Discover 
